Evidence map›Paper›PMID 39266668›Full record

ArticleCommunications biology2024

Expanding the CRISPR base editing toolbox in Drosophila melanogaster.

Michael Clark, Christina Nguyen, Hung Nguyen, Aidan Tay, Samuel J Beach, Maciej Maselko, Víctor López Del Amo

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michael ClarkApplied BioSciences, Macquarie University, Sydney, NSW, Australia.
Christina NguyenCenter for Infectious Diseases, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, University of Texas Health Science Center, Houston, TX, USA.
Hung NguyenApplied BioSciences, Macquarie University, Sydney, NSW, Australia.
Aidan TayApplied BioSciences, Macquarie University, Sydney, NSW, Australia.ORCID 0000-0003-1315-4896
Samuel J BeachApplied BioSciences, Macquarie University, Sydney, NSW, Australia.ORCID 0000-0002-4292-1567
Maciej MaselkoApplied BioSciences, Macquarie University, Sydney, NSW, Australia. maciej.maselko@mq.edu.au.ORCID 0000-0001-7831-848X
Víctor López Del AmoCenter for Infectious Diseases, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, University of Texas Health Science Center, Houston, TX, USA. victor.lopezdelamo@uth.tmc.edu.ORCID 0000-0002-5567-3072

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CRISPR base editors can introduce point mutations into DNA precisely, and cytosine base editors (CBEs) catalyze C to T transitions. While CBEs have been thoroughly explored in cell culture and organisms such as mice, little is known about DNA base editing in insects. In this study, we evaluated germline editing rates of three different CBEs expressed under actin (ubiquitous) or nanos (germline) promoters utilizing Drosophila melanogaster. The original Rattus norvegicus-derived cytosine deaminase APOBEC1 (rAPO-1) displayed high base editing rates (~99%) with undetectable indel formation. Additionally, we show that base editors can be used for generating male sterility and female lethality. Overall, this study highlights the importance of promoter choice and sex-specific transmission for efficient base editing in flies while providing new insights for future genetic biocontrol designs in insects.

Indexed as

CRISPR-Cas SystemsDrosophila melanogasterGene EditingAnimalsDrosophila ProteinsFemaleMalePromoter Regions, GeneticDrosophila Proteins

Identifiers

PMID39266668
PMCPMC11392945

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.